Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing

a technology of micrornas and inhibitors, which is applied in the direction of biochemistry apparatus and processes, instruments, drug compositions, etc., can solve the problems of obscurity of the factors responsible for senescence-induced gene expression alterations, and achieve the effect of preventing and/or attenuating skin ageing

Inactive Publication Date: 2017-02-14
CHANEL PARFUMS BEAUTE SAS
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a way to test if new substances can stop or slow down the aging process on your skin by testing them against other things that cause it to lose its elasticity over time. This helps us better identify potential drugs that could help fight this issue.

Problems solved by technology

The technical problem addressed in this patent is how to identify effective substances against cellular senescences caused by environmental factors like radiation exposure, chemicals, and other factors that can lead to cellular senescence.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing
  • Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing
  • Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing

Examples

Experimental program
Comparison scheme
Effect test

example 1

Material and Methods

[0107]Cell Culture and Transfection

[0108]Neonatal Human Primary Dermal Fibroblasts (HDFn, Cascade, Invitrogen, Carlsbad, Calif., USA) were cultured in 106 medium added with LSGS growth supplements (Cascade). Cells were passaged usually once a week, at each passage the harvested cells number and seeded cell number were recorded in order to calculate the population doublings occurring between passages and the population doubling time. At each passage different aliquots of the cells were harvested to extract in triplicate RNA and proteins and an aliquot was submitted to senescence activated β-galactosidase staining in order to assay the senescent or non-senescent state of the cells.

[0109]Human primary fibroblasts were transfected with human pre-miR 134, anti-miR-134, pre-miR-152, anti-miR-152 and scramble sequence as negative control (Ambion, Tex., USA) using the Lipofecatmine RNAimax transfection reagent (Invitrogen) according to manufacturer protocols. 24 hrs after t

example 2

Cosmetic Composition (O / W Serum)

[0134]The following composition may be prepared in a classical manner for the man skilled in the art.

[0135]The active agent is prepared as follows:

[0136]The wood of Andira coriacea (i.e. Bois d'Ange) was extracted with ethanol, yielding 386 mg of crude extract after evaporation under reduced pressure. The crude extract was then purified by reverse phase preparative HPLC(C18 Varian Pursuit XRS, 250 mm×41.1 mm×5 nm) using a gradient of H2O+0.1% formic acid and MeOH (from H2O+FA / MeOH 70:30 to 60:40 in 17 min at 60 mL min-1) to afford pure Coatline A (12.3 mg) and Coatline B (40.2 mg).

[0137]

INCI name% (w / w)WaterQSP 100.00Chelating agent0.05pH balance0.05Preservatives0.05Glycol3.25AMMONIUM ACRYLOYLDIMETHYLTAURATE / VP1.20COPOLYMERACRYLATES / C10-30 ALKYL ACRYLATE0.20CROSSPOLYMERGLYCERIN3.00GLYCERYLPOLYMETHACRYLATE4.18SODIUM ACETYLATED HYALURONATE0.05Oil10.00 ALCOHOL8.00PERFUMES0.30Coatlines obtained as described above0.05

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

Identification and use of compounds which inhibit the expression or activity of micro-RNAs for preventing and/or attenuating ageing. An in vitro method for screening for candidate compounds for preventing and/or attenuating ageing of the skin including (a) bringing at least one test compound in contact with a sample of fibroblasts, (b) measuring the expression or the activity of at least one microRNA chosen from miR-134 and miR-152 in said fibroblasts, and (c) selecting the compounds for which an inhibition of at least 20%, preferably at least 30%, preferably at least 40% of the expression or an inhibition of at least 20%, preferably at least 30%, preferably at least 40% of the activity of at least one microRNA is measured in the fibroblasts treated in (a) compared with the untreated fibroblasts.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner CHANEL PARFUMS BEAUTE SAS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products